Verrica Pharmaceuticals Reports Q2 2026 Financial Results, Schedules Call

What Happened
Verrica Pharmaceuticals Inc. announced its financial results for the quarter and six months ended June 30, 2026 via a press release dated August 6, 2026 and filed an 8‑K disclosing those results and related corporate highlights. The company also provided information about a conference call to discuss the quarterly results and recent developments. The press release has been furnished as Exhibit 99.1 to the Form 8‑K.

Key Details

• Press release announcing results and a conference call was issued and furnished as Exhibit 99.1 to the Form 8‑K (filed Aug 6, 2026).
• Results cover the quarter and six months ended June 30, 2026 (quarterly results / earnings period).
• The company scheduled a conference call to discuss the results and recent corporate highlights (management commentary opportunity).
• The Form 8‑K includes the required exhibit filings (press release/in-line XBRL cover page).

Why It Matters
This filing gives investors the company’s latest earnings and financial condition for Q2 and the first half of 2026, and it signals an upcoming management call where revenue, operating results, and business updates will be discussed. Review the furnished press release (Exhibit 99.1) and consider listening to the conference call for details on revenue, earnings, guidance, or operational changes before making investment decisions. This 8‑K does not report executive changes, mergers, or other corporate transactions.